🇺🇸 FDA
Patent

US 8404650

Methods of treating cancer with doxazolidine and prodrugs thereof

granted A61KA61K31/704A61P

Quick answer

US patent 8404650 (Methods of treating cancer with doxazolidine and prodrugs thereof) held by The Regents of the University of Colorado, a Body Corporate expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/704, A61P, A61P35/00